259 related articles for article (PubMed ID: 33865422)
1. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
2. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA Differentiation Antagonizing Nonprotein Coding RNA (DANCR) Promotes Proliferation and Invasion of Pancreatic Cancer by Sponging miR-214-5p to Regulate E2F2 Expression.
Yao Z; Chen Q; Ni Z; Zhou L; Wang Y; Yang Y; Huang H
Med Sci Monit; 2019 Jun; 25():4544-4552. PubMed ID: 31213582
[TBL] [Abstract][Full Text] [Related]
4. The Lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell Proliferation, Migration and EMT Phenotype Formation Through Sponging Mir-382.
Zhao L; Sun H; Kong H; Chen Z; Chen B; Zhou M
Cell Physiol Biochem; 2017; 42(6):2145-2158. PubMed ID: 28813705
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
6. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
[TBL] [Abstract][Full Text] [Related]
7. LncRNA
Wang J; Han Y; Zhang T; Li J; Xu B
Front Biosci (Landmark Ed); 2023 Oct; 28(10):270. PubMed ID: 37919051
[TBL] [Abstract][Full Text] [Related]
8. LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway.
Wu X; Xia T; Cao M; Zhang P; Shi G; Chen L; Zhang J; Yin J; Wu P; Cai B; Lu Z; Miao Y; Jiang K
Technol Cancer Res Treat; 2019; 18():1533033819887962. PubMed ID: 31769353
[TBL] [Abstract][Full Text] [Related]
9. LncRNA PART1 facilitates the malignant progression of colorectal cancer via miR-150-5p/LRG1 axis.
Lou T; Ke K; Zhang L; Miao C; Liu Y
J Cell Biochem; 2020 Oct; 121(10):4271-4281. PubMed ID: 31898365
[TBL] [Abstract][Full Text] [Related]
10. LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis.
Zhu YJ; Jiang DM
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8175-8185. PubMed ID: 31646607
[TBL] [Abstract][Full Text] [Related]
11. Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis.
Li B; Lou G; Zhang J; Cao N; Yu X
BMC Cancer; 2022 Jan; 22(1):124. PubMed ID: 35100978
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA LINC01963 inhibits progression of pancreatic carcinoma by targeting miR-641/TMEFF2.
Li K; Han H; Gu W; Cao C; Zheng P
Biomed Pharmacother; 2020 Sep; 129():110346. PubMed ID: 32559621
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway.
Lei S; He Z; Chen T; Guo X; Zeng Z; Shen Y; Jiang J
J Exp Clin Cancer Res; 2019 Nov; 38(1):470. PubMed ID: 31747939
[TBL] [Abstract][Full Text] [Related]
14. LncRNA PART1 promotes lung squamous cell carcinoma progression via miR-185-5p/Six1 axis.
Cao Y; Zhang R; Luo X; Yang Y
Hum Exp Toxicol; 2021 Jun; 40(6):960-976. PubMed ID: 33300377
[TBL] [Abstract][Full Text] [Related]
15. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
[TBL] [Abstract][Full Text] [Related]
16. LncRNA differentiation antagonizing non-protein coding RNA promotes proliferation and invasion through regulating miR-135a/NLRP37 axis in pancreatic cancer.
Tang Y; Cao G; Zhao G; Wang C; Qin Q
Invest New Drugs; 2020 Jun; 38(3):714-721. PubMed ID: 31267381
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
18. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR.
Wei W; Liu Y; Lu Y; Yang B; Tang L
J Cell Biochem; 2017 Oct; 118(10):3349-3358. PubMed ID: 28295543
[TBL] [Abstract][Full Text] [Related]
19. LncRNA PART1 regulates colorectal cancer via targeting miR-150-5p/miR-520h/CTNNB1 and activating Wnt/β-catenin pathway.
Zhou T; Wu L; Ma N; Tang F; Zong Z; Chen S
Int J Biochem Cell Biol; 2020 Jan; 118():105637. PubMed ID: 31669140
[TBL] [Abstract][Full Text] [Related]
20. The Role of Tumor-related LncRNA PART1 in Cancer.
Chen J; Meng E; Lin Y; Shen Y; Hu C; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4152-4159. PubMed ID: 34225608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
